CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice and Policy

ONCOLOGY. Vol. 25 No. 8
PRACTICE & POLICY 

Achieving Meaningful Use of Electronic Health Records for the Oncologist

By David Eagle, MD1, Thomas R. Barr, MBA2 | July 11, 2011
1Lake Norman Oncology, Mooresville/Huntersville, North Carolina; Dr. Eagle is also president of the Community Oncology Alliance.
2Mr. Barr is an executive with Altos Solutions in Los Altos, California, and the general manager of Oncology Metrics, a division of Altos Solutions. He is a past president of the Administrators of the Oncology Hematology Assembly (AOHA) of the Medical Group Management Association, and he was the first liaison between AOHA and the American Society of Clinical Oncologists (ASCO).

Interest in Electronic Health Records

In 2003, the Institute of Medicine (IOM) issued a report outlining key capabilities of an electronic health record.[1] The report described the interest of private and public entities in moving providers from paper-based records to electronic storage of health information. Rationales for this transition included quality improvement, greater patient safety, and control of escalating health care costs through improved efficiency. To help identify the desired core EHR system functionalities, the IOM committee formulated five criteria:

• Improvement in patient safety.

• Support for the delivery of effective patient care.

• Facilitation of the management of chronic conditions.

• Improvement in efficiency.

• Feasibility of implementation.

The core functionalities identified were:

• Health information and data.

• Results management.

• Order entry/management.

• Decision support.

• Electronic communication and connectivity.

• Patient support.

• Administrative processes.

• Reporting and population health management.

The report expected transition to take longer for physicians’ practices as compared with hospitals because of differences in the availability of financial resources for IT investment. As anticipated, adoption of EHRs by physician offices has been slow. Barriers to adoption have included cost, lack of financial return, and logistical challenges in implementing EHRs.[2] To address this problem, the American Recovery and Reinvestment Act (ARRA) of 2009 allocated approximately $19 billion to act as a financial incentive for physicians and hospitals to adopt EHRs.2


David Eagle, MD

Compared with recent physician incentive programs such as the Physician Quality Reporting Initiative (PQRI), the ARRA incentive program provides more generous financial rewards. For physicians satisfying requirements in 2011 or 2012, the payments can be as high as $18,000 per physician. The payments gradually decline over the following 4 years. Penalties will then follow beginning in 2015. However, for practices to receive the financial incentive, they must do more than use an EHR in their practice. Rather, they must demonstrate that they are achieving “meaningful use” of their EHR by meeting multiple criteria.

Our practice, Lake Norman Oncology, became among the first oncology practices in the country to achieve meaningful use. Our practice adopted an EHR in 2010. In April, 2011, with the support of our EHR vendor, Altos Solutions, we were able to complete the attestation process shortly after CMS opened its portal for submission of data. Subsequently, the practice has received payment in the amount of $18,000 per physician.

Here, we provide an overview of the criteria for meaningful use, the challenges most offices can expect to encounter in achieving these criteria, and the process of attestation itself. The rules and regulations for meaningful use attestation are complex. This article is primarily intended to provide an introduction to the topic and to discuss how meaningful use of EHRs fits into the broader evolution of our health system.

Achieving Meaningful Use of Electronic Health Records


Thomas R. Barr, MBA

To achieve meaningful use in the first phase of EHR roll-out, the ARRA outlined three broad categories of activities that must be engaged in. First, physician offices must use a certified EHR in a “meaningful” manner, such as e-prescribing. Second, the EHR must be used to exchange health information electronically. Third, providers must submit clinical quality measures. This initial phase of meaningful use focuses on data capture and sharing. In the future, it is expected that meaningful use will require advanced clinical processes, followed later still by demonstration of improved outcomes.[3]

To achieve meaningful use in 2011, eligible professionals must use an EHR platform that has been certified by CMS for the incentive program. Criteria for meaningful use must be satisfied for a continuous 90 day period. The meaningful use criteria include fifteen “core” and ten “menu set” items. All core criteria must be met. The core criteria are:

1. Computerized provider order entry (30%).

2. E-prescribing. (40%)

3. Report of ambulatory clinical quality measures.

4. Implementation of one clinical decision support rule.

5. Electronic copy of patients’ health information provided per patient request. (50%)

6. Clinical summaries provided for patients for each office visit. (50%)

7. Drug-drug and drug-allergy interaction checks performed.

8. Demographics recorded. (50%)

9. Updated problem list of current diagnoses maintained. (80%)

10. Current medication list maintained. (80%)

11. Current medication allergy list maintained. (80%)

12. Changes in vital signs recorded and charted. (50%)

13. Smoking status for patients older than 13 years recorded. (50%)

14. Capability to exchange key clinical information among providers of care and patient-authorized entities electronically.

15. Protection of electronic health information.

In addition, eligible professionals must satisfy five of ten menu set objectives:

1. Drug-formulary checks.

2. Incorporation of clinical lab test results as structured data. (40%)

3. Lists of patients generated by specific conditions.

4. Reminders sent to patients per patient preference for preventative and follow up care. (20%)

5. Patients provided with timely electronic access to their health information. (10%)

6. Use of certified EHR technology to identify patient-specific education resources and provide to patient if appropriate. (10%)

7. Medication reconciliation. (50%)

8. Summary of care record for each transition of care or referral. (50%)

9. Capability to submit electronic data to immunization registries/systems.

10. Capability to provide electronic syndromic surveillance data to public health agencies.

The last two items listed above are considered public health objectives. At least one of these items must be included when reporting from the menu set. Many but not all items have specific thresholds of performance and these performance thresholds are included in parenthesis above. Each measure has a specific denominator that creates additional nuance. For many measures, the denominator is unique patients during the reporting period. This means that a patient who is seen every two weeks for chemotherapy during the reporting period counts the same as a patient who is seen only once during the same 90 day period.

Item #3 on the core measure list requires the reporting of clinical quality measures. Satisfying this measure requires reporting on all of the following three core quality measures:

• Hypertension: blood pressure measurement.

• Tobacco use assessment and intervention.

• Adult weight screening and follow up.

For practices unable to fulfill a core quality measure, one or more of the following alternate core measures can be chosen:

• Weight assessment and counseling for children and adolescents.

• Influenza immunization for patients 50 years old or older.

• Childhood immunization status.

In addition, 3 additional clinical quality measures must be selected from a list of 38. Most of these measures are not oncology related but items do include measures for breast and colon cancer treatment.

Our office personnel devoted substantial time to understanding each criteria, understanding the performance thresholds, and determining the workflow changes needed to satisfy each item. Responsibilities for satisfying each item were divided among office departments (eg, front desk activities, physician activities, physician nurse activities, and chemotherapy nurse activities). Some measures, such as electronic prescribing, required the combined efforts of multiple departments. Based on our experience, we would advise choosing more than five menu set items to ensure that the minimum criteria are met at the time of attestation. Our EHR platform provided the capability to run reports on meaningful use criteria with specific performance thresholds. This allowed real time feedback on performance. For any measures not meeting performance thresholds prior to the end of 90-day period, work flow processes and personnel responsibilities were reviewed and adjusted.

The Attestation Process

In 2011, qualifying for meaningful use done is by attestation. In future years, it is anticipated that the Centers for Medicare and Medicaid Services (CMS) will determine performance based on a query of the EHR platform itself. Prior to attestation, providers must register for the program on the EHR Incentive Program website. This is unlike the PQRI program, in which no registration is required. Registration is at the individual provider level, and the provider’s NPI number is submitted.

After satisfying the meaningful use criteria for the continuous 90-day period, practices report their specific performance metrics for each item. It is mandatory that the EHR itself generate the data for attestation. Physicians cannot determine performance metrics through any process external to the EHR. During attestation, providers report numerator, denominator, and any applicable exclusions for the meaningful use criteria and attest that they have satisfied all of the program requirements. At the completion of the attestation process, the CMS site will report whether or not attestation has been successful.

The Future

Meaningful use of EHRs likely represents a component of the future model of health care reimbursement. Instead of rewarding physicians solely for patient care, physician reimbursement will probably be tied to active participation in the evolution of the health care delivery process. This evolution includes the adoption of interoperable electronic medical record platforms. The first phase focuses on data entry and transferability. In the future, meaningful use will evolve as outlined in the Figure.


Conceptual Approach to Meaningful Use

For the next few years, incentive payments will be provided for achieving meaningful use. Afterwards, physicians will receive reduced reimbursement for failing to use an EHR in the format the government mandates. For physicians who understandably already practice with a deep sense of frustration due to the increasing complexity and expanding scope of their responsibilities, this does not represent welcome news.

However, the evolution of EHRs can represent an opportunity for physician empowerment. All practicing physicians are aware of the barriers that government and private payers create in providing effective, high quality healthcare. Numerous pre-certifications, denial of needed imaging or therapy, and excessive out of pocket expense for care are just a few of these barriers. Effectively designed EHR platforms could help track these barriers. We strongly suspect that CMS and other agencies will mine data from EHRs in the future to use in making policy arguments. We think it is advisable for the oncology community to prepare for this by planning to do the same. Physicians are central to the value creation process in healthcare. We need to ensure that the EHR data capturing and metrics reflect this.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Stephen Strum | July 25, 2011 11:38 AM EDT

I find the description of many of the above items to be difficult to understand. I have observed that almost all of the physicians using some form of EHR are basically using this to justify billing at a higher level and are simply doing cut and paste from prior office visits. I consider this highly unethical and unprofessional and perhaps fraudulent. Very rarely (I cannot think of one case) have I seen any EHR where mention is made of checking for drug interactions. I do see mention made on a painfully repetitive manner of the same diagnoses listed to where if one actually reads the office visit "consultations"it becomes a painful experience.
On the contrary, over the course of many years I have developed a simple approach to an EHR which is "resolution" based and which fulfills most of the criteria above (at least the ones I can understand). I would be happy to share this with anyone and it costs nothing.
Stephen B. Strum, MD, FACP
Medical Oncologist Specializing in Prostate Cancer
Ashland, OR





REFERENCES:

1. Institute of Medicine. Key capabilities of an electronic health record: Letter Report. Available at http://www.nap.edu/catalog/10781.html. Accessed May 10, 2011.

2. Blumenthal D. Stimulating the adoption of health information technology. N Engl J Med. 2009;360:1477-9.

3. Medicare & Medicaid EHR incentive program. Meaningful use stage 1 requirements overview. Available at https://www.cms.gov/EHRIncentivePrograms/Downloads/MU_Stage1_ReqOverview.pdf. Accessed May 17, 2011.


 
RELATED CONTENT

Preventing Burnout in Oncology
June 18, 2013
Supreme Court Ruling Invalidates Myriad’s BRCA Gene Patents
June 14, 2013
How the Sequester Cuts Are Harming Oncology
ONCOLOGY,  May 15, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
US Cancer Organizations Say Medicare Cuts Will Negatively Impact Cancer Patients
April 29, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Health Care
Evidence on Health Care
Guidelines on Health Care
Patient Education on Health Care
Clinical Trials on Health Care
Practical Articles on Health Care
Research and Reviews on Health Care
All "Health Care" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy